RECRUITINGN/A

Application of Radiomics in Breast Cancer

Little is known about the correlation between ultrasound characteristics (conventional, elastography and contrast enhanced ultrasound (CEUS) )and pathological prognostic factors in breast cancer. The aim of this study was to explore the correlation between ultrasound characteristics and pathological prognostic factors using radiomics.

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

2,000 participants

Sites

1 locations

Start Date

January 2018

Completion

December 2023

Breast CancerUltrasoundElastographyPathologyRadiomics

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

2,000

participants

Sites

locations

Duration

10.9 years

total trial span

Rate

pts/month needed

Jan 2018Month 102 of 131Dec 2023

78% of trial timeline elapsed29 months to primary endpoint

At 1 sites, each site needs to enroll approximately 15.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

metastasis

through study completion, an average of 1 year

lymph node metastasis and/or distant metastasis

death

through study completion, an average of 1 year

death

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

RECRUITINGN/A

Application of Radiomics in Breast Cancer

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

2,000 participants

Sites

1 locations

Start Date

January 2018

Completion

December 2023

Breast CancerUltrasoundElastographyPathologyRadiomics

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

2,000

participants

Sites

locations

Duration

10.9 years

total trial span

Rate

pts/month needed

Jan 2018Month 102 of 131Dec 2023

78% of trial timeline elapsed29 months to primary endpoint

At 1 sites, each site needs to enroll approximately 15.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

metastasis

through study completion, an average of 1 year

lymph node metastasis and/or distant metastasis

death

through study completion, an average of 1 year

death

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Application of Radiomics in Breast Cancer

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Application of Radiomics in Breast Cancer

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)